| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 2, 2020 | 140.00 | 148.00 | 138.60 | 144.00 | 23,993 |
| Jul 1, 2020 | 139.00 | 148.80 | 138.60 | 144.00 | 11,302 |
| Jun 30, 2020 | 147.00 | 148.00 | 140.251 | 144.00 | 12,311 |
| Jun 29, 2020 | 144.00 | 147.00 | 136.00 | 144.00 | 73,844 |
| Jun 26, 2020 | 136.50 | 140.00 | 133.00 | 136.50 | 5,166 |
| Name | ReNeuron Group | Epic | RENE |
|---|---|---|---|
| ISIN | GB00BF5G6K95 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 3,000 | Prev Close | 141.50 |
| Shares in Issue (m) | 31.83 | Market Cap (£m) | 45.84 |
| PE Ratio | -3.19 | Div per Share () | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -45.20 | EPS Growth (%) | 18.85 |
| PEG | -0.17 | DPS Growth (%) | n/a |
| ROCE | -73.36 | Net Gearing | -42.15 |
| Quick Ratio | 4.04 | Current Ratio | 4.04 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 09 Nov | Stifel | Buy | 141.50 | 13.00 | 13.00 | Reiterates |
| 29 Jun | N+1 Singer | Buy | 141.50 | - | - | Reiterates |
| 27 Apr | N+1 Singer | Buy | 141.50 | 9.00 | 9.00 | Reiterates |
| 04 Apr | Stifel | Buy | 141.50 | 15.00 | 15.00 | Reiterates |
| 04 Jan | N+1 Singer | Buy | 141.50 | 9.00 | 9.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 18 Apr 2019 | Christopher Evans | Buy | 10,000 @ 2.287p | £22,870.00 |
| 12 Apr 2019 | Michael Hunt | Sale Post-Exercise | 988 @ 2.47p | £2,440.00 |
| 12 Apr 2019 | Michael Hunt | Exercise | 3,478 @ 1.00p | £3,478.00 |
| 11 Apr 2019 | John Berriman | Buy | 80,000 @ 2.25p | £180,000.00 |
| 11 Apr 2019 | Christopher Evans | Buy | 4,500 @ 2.215p | £9,968.00 |
You can opt out at any time.
